| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC0322 |
| Trial ID | NCT02813837 |
| Disease | B-Cell Lymphoma | B-Cell Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Recruitment status | Unknown |
| Title | Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies |
| Year | 2015 |
| Country | China |
| Company sponsor | Innovative Cellular Therapeutics Co., Ltd. |
| Other ID(s) | SCT019-01 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||